Nanjing Pharmaceutical Group Company Limited (SHA:600713)

China · Delayed Price · Currency is CNY

5.07

+0.03 (0.60%)

Jul 31, 2026, 3:00 PM CST

SHA:600713 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	54,560	54,963	53,696	53,590	50,222	45,123
Revenue Growth	1.05%	2.36%	0.20%	6.71%	11.30%	13.33%
Gross Profit	3,386	3,366	3,355	3,307	3,252	2,934
Operating Income	1,355	1,349	1,537	1,500	1,389	1,301
Net Income	622.04	624.83	570.63	577.83	595.67	505.18
Earnings Per Share	0.41	0.43	0.44	0.45	0.47	0.48
EPS Growth	-8.02%	-2.74%	-1.57%	-6.32%	-2.06%	34.35%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	2,223	3,264	4,563	2,372	2,328	2,095
Total Debt	13,165	9,375	10,196	9,110	12,219	9,867
Net Cash (Debt)	-10,942	-6,111	-5,634	-6,738	-9,891	-7,772
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-7.29	-4.17	-4.32	-5.19	-7.89	-7.46

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-1,502	91.81	2,136	1,906	-682.31	695.33
Capital Expenditures	-252.96	-251.37	-544.76	-158.22	-155.28	-306.54
Free Cash Flow	-1,755	-159.57	1,591	1,748	-837.59	388.79
Free Cash Flow Growth	-	-	-8.99%	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	6.21%	6.12%	6.25%	6.17%	6.48%	6.50%
Operating Margin	2.48%	2.45%	2.86%	2.80%	2.77%	2.88%
Pretax Margin	2.13%	2.11%	1.87%	1.83%	1.80%	1.86%
Profit Margin	1.14%	1.14%	1.06%	1.08%	1.19%	1.12%
FCF Margin	-3.22%	-0.29%	2.96%	3.26%	-1.67%	0.86%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	0.170	0.170	0.170	0.160	0.140	0.120
Dividend Per Share Growth	0%	0%	6.25%	14.29%	16.67%	9.09%
Dividend Yield	3.35%	3.22%	3.66%	3.67%	3.11%	2.85%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	12.24	11.44	11.38	10.98	11.26	10.12
Forward PE	-	27.42	27.42	27.42	27.42	27.42
P/FCF Ratio	-	-	4.08	3.63	-	13.15
PS Ratio	0.12	0.13	0.12	0.12	0.13	0.11